SpringWorks Therapeutics, Inc.
SWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,678,418 | $2,304,024 | $1,386,087 | $3,005,893 |
| - Cash | $69,751 | $176,053 | $67,490 | $103,961 |
| + Debt | $7,912 | $7,057 | $5,251 | $1,291 |
| Enterprise Value | $2,616,579 | $2,135,028 | $1,323,848 | $2,903,223 |
| Revenue | $191,589 | $5,447 | $6,147 | $0 |
| % Growth | 3,417.3% | -11.4% | – | – |
| Gross Profit | $179,039 | $5,025 | $4,251 | -$490 |
| % Margin | 93.4% | 92.3% | 69.2% | – |
| EBITDA | -$274,663 | -$341,346 | -$275,521 | -$172,978 |
| % Margin | -143.4% | -6,266.7% | -4,482.2% | – |
| Net Income | -$258,131 | -$325,104 | -$277,417 | -$173,212 |
| % Margin | -134.7% | -5,968.5% | -4,513% | – |
| EPS Diluted | -3.48 | -5.15 | -5.21 | -3.59 |
| % Growth | 32.4% | 1.2% | -45.1% | – |
| Operating Cash Flow | -$175,599 | -$222,795 | -$161,563 | -$127,877 |
| Capital Expenditures | -$4,451 | -$7,385 | -$10,196 | -$2,016 |
| Free Cash Flow | -$180,050 | -$230,180 | -$171,759 | -$129,893 |